SG301 is a humanized IgG1 monoclonal antibody that recognizes a unique epitope on CD38. It is currently under clinical investigation for the treatment of hematological malignancies and the preliminary outcome from phase I study has suggested a promising best-in-class potential.
Copyright Rm. 301, F3, Building C, Block 2, No. 688, Bin'an Road, Changhe Zhejiang ICP Filing No. 18039044
